drugset / Trial / NCT03545516

Wound Infiltration as Part of an Opioid Free Pain Management Pathway Following Cesarean Delivery

NCT03545516

Phase 2 Unknown 540 enrolled Richmond University Medical Center
RandomizedParallel-groupTriple-blindTreatment

Summary

This study will investigate the effect of three types of wound infiltration on post Cesarean opioid analgesia consumption when used in conjunction with an opioid free postoperative analgesia pathway.

Timeline

Start
2018-09-17
Primary completion
2018-11-01
Completion
2018-11-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupivacaine Other / unclassified 0.75 % Other
Subject Bupivacaine Other / unclassified 20 ml Other
Subject Bupivacaine Other / unclassified 150 mg Other
Subject Dexmedetomidine Other / unclassified 1.5 ug/kg Other